Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    MacroGenics Inc.

    NASDAQ: MGNX · Real-Time Price · USD
    1.50
    -0.02 (-1.32%)
    At close: Jun 16, 2025, 3:59 PM
    1.45
    -3.65%
    Pre-market: Jun 17, 2025, 04:57 AM EDT

    MacroGenics Statistics

    Share Statistics

    MacroGenics has 63.09M shares outstanding. The number of shares has increased by 0.73% in one year.

    Shares Outstanding

    n/a
    		 63.09M

    Shares Change (YoY)

    n/a
    		 0.73%

    Shares Change (QoQ)

    n/a
    		 0.52%

    Owned by Institutions (%)

    n/a
    		 89.39%

    Shares Floating

    n/a
    		 57.94M

    Failed to Deliver (FTD) Shares

    n/a
    		 3

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 6.12M, so 9.7% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 6.12M

    Short % of Shares Out

    n/a
    		 9.7%

    Short % of Float

    n/a
    		 11.94%

    Short Ratio (days to cover)

    n/a
    		 18.41

    Valuation Ratios

    The PE ratio is -3.04 and the forward PE ratio is -0.87. MacroGenics's PEG ratio is 0.

    PE Ratio

    n/a
    		 -3.04

    Forward PE

    n/a
    		 -0.87

    PS Ratio

    n/a
    		 1.37

    Forward PS

    n/a
    		 0.7

    PB Ratio

    n/a
    		 1.75

    P/FCF Ratio

    n/a
    		 -2.82

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for MacroGenics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.92, with a Debt / Equity ratio of 0.32.

    Current Ratio

    n/a
    		 3.92

    Quick Ratio

    n/a
    		 3.92

    Debt / Equity

    n/a
    		 0.32

    Debt / EBITDA

    n/a
    		 -0.65

    Debt / FCF

    n/a
    		 -0.52

    Interest Coverage

    n/a
    		 -99.17

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $435,011.73

    Profits Per Employee

    n/a
    		 $-196,381.23

    Employee Count

    n/a
    		 341

    Asset Turnover

    n/a
    		 0.57

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 944K

    Effective Tax Rate

    n/a
    		 -1.43%

    Stock Price Statistics

    The stock price has increased by -65.03% in the last 52 weeks. The beta is 1.63, so MacroGenics's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.63

    52-Week Price Change

    n/a
    		 -65.03%

    50-Day Moving Average

    n/a
    		 1.49

    200-Day Moving Average

    n/a
    		 2.71

    Relative Strength Index (RSI)

    n/a
    		 47.39

    Average Volume (20 Days)

    n/a
    		 1,155,874

    Income Statement

    In the last 12 months, MacroGenics had revenue of 148.34M and earned -66.97M in profits. Earnings per share was -1.07.

    Revenue

    n/a
    		 148.34M

    Gross Profit

    n/a
    		 136.04M

    Operating Income

    n/a
    		 -110.58M

    Net Income

    n/a
    		 -66.97M

    EBITDA

    n/a
    		 -57.37M

    EBIT

    n/a
    		 -64.91M

    Earnings Per Share (EPS)

    n/a
    		 -1.07
    Full Income Statement

    Balance Sheet

    The company has 182.84M in cash and 37.46M in debt, giving a net cash position of 145.38M.

    Cash & Cash Equivalents

    n/a
    		 182.84M

    Total Debt

    n/a
    		 37.46M

    Net Cash

    n/a
    		 145.38M

    Retained Earnings

    n/a
    		 -1.17B

    Total Assets

    n/a
    		 224.56M

    Working Capital

    n/a
    		 126.65M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -68.37M and capital expenditures -3.71M, giving a free cash flow of -72.08M.

    Operating Cash Flow

    n/a
    		 -68.37M

    Capital Expenditures

    n/a
    		 -3.71M

    Free Cash Flow

    n/a
    		 -72.08M

    FCF Per Share

    n/a
    		 -1.15
    Full Cash Flow Statement

    Margins

    Gross margin is 91.71%, with operating and profit margins of -74.54% and -45.14%.

    Gross Margin

    n/a
    		 91.71%

    Operating Margin

    n/a
    		 -74.54%

    Pretax Margin

    n/a
    		 -44.51%

    Profit Margin

    n/a
    		 -45.14%

    EBITDA Margin

    n/a
    		 -38.67%

    EBIT Margin

    n/a
    		 -74.54%

    FCF Margin

    n/a
    		 -48.59%

    Dividends & Yields

    MGNX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for MGNX is $3, which is 100% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $3

    Price Target Difference

    n/a
    		 100%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 9
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -6.62

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist